PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90647623 |
Filing Date: 04/15/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90647623 |
---|---|
MARK INFORMATION | |
*MARK | TRANSLATE THERAPEUTICS |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | TRANSLATE THERAPEUTICS |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Translate Bio, Inc. |
*MAILING ADDRESS | 29 Hartwell Avenue |
*CITY | Lexington |
*STATE (Required for U.S. applicants) |
Massachusetts |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
02421 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Medical and scientific research |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Christina M. Licursi |
ATTORNEY DOCKET NUMBER | R06932000201 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Wolf, Greenfield & Sacks, P.C. |
STREET | 600 Atlantic Avenue |
CITY | Boston |
STATE | Massachusetts |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 02210 |
PHONE | 617-646-8000 |
FAX | 617-646-8646 |
EMAIL ADDRESS | cxltrademarks@wolfgreenfield.com |
OTHER APPOINTED ATTORNEY | Michael A. Albert, Nicole Davis Amar, Eric L. Amundsen, Michael J. Attisha, C. Hunter Baker, Jason W. Balich, Melissa Beede, Brandon S. Blackwell, Joseph M. Bowler, Joshua M. Brandt, Kady S. Bruce, David F. Cauble, Tani Chen, Gitanjali Chimalakonda, Thomas S. Chlebeck, Bryan S. Conley, Gregory F. Corbett, Elizabeth A. DiMarco, Heather J. DiPietrantonio, Stuart V. Duncan Smith, Roque El-Hayek, Neil P. Ferraro, Emma L. Frank, Thomas A. Franklin, Susmita A. Gadre, Emily J. Gardel, Edward R. Gates, David S. Gesner, Richard F. Giunta, Matthew H. Grady, Patricia L. Granahan, Michael A. Greene, Eric P. Greenwald, Philip J. Hamzik, James M. Hanifin, Jr., John S. Harmon, , Jason M. Honeyman, Gerald B. Hrycyszyn, Jeffrey D. Hsi, Elisabeth H. Hunt, Robert E. Hunt, Daniel M. Huttle, Robert A. Jensen, Marc S. Johannes, Oona M. Johnstone, Hunter D. Keeton, Jessamine M. Lee, Christina M. Licursi, Helen C. Lockhart, Chelsea Loughran, Kevin MacDonald, Robert T. Maldonado, Ethan W. Marks, Kira-Khanh McCarthy, William R. McClellan, Gabriel J. McCool, Marie A. McKiernan, Anshul M. Mehra, Andrea D. Merin, Kevin Mosier, Michele Moresco, James H. Morris, Elizabeth S. Mulski, Gregory S. Nieberg, Michelle K. Nyein, Timothy J. Oyer, Zachary P. Piccolomini, Michael J. Pomianek, Randy J. Pritzker, Michael N. Rader, Jonathan B. Roses, Daniel G. Rudoy, Edward J. Russavage, Eric J. Rutt, Robert N. Sahr, Anant K. Saraswat, Turhan F. Sarwar, Tonia Sayour, Claire E. Schuster, Karan Singh, Amanda Slade, Laura B. Sole, Nathan R. Speed, Charles T. Steenburg, John L. Strand, Shirley Tan, Andrew J. Tibbetts, Maria A. Trevisan, Michael J. Twomey, John R. Van Amsterdam, Ryan M. Van Olst, Amanda L. Varrichione, Janice A. Vatland, Jessica A. vonReyn, Robert H. Walat, Patrick R.H. Waller, Edmund J. Walsh, Jennifer J. Wang, Daniel T. Wehner, John L. Welch, Andrew W. Williams, Douglas R. Wolf, Daniel W. Young, Lock See Yu-Jahnes, William Wei Zhang, Chelsea E. Witte-Garcia, Adam Z. Zeiger, Norman H. Zivin |
CORRESPONDENCE INFORMATION | |
NAME | Christina M. Licursi |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cxltrademarks@wolfgreenfield.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | NOT PROVIDED |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 2 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 700 |
*TOTAL FEES PAID | 700 |
SIGNATURE INFORMATION | |
ORIGINAL PDF FILE | hw_3814021162-121222300_. _R0693.20002US01___signed _TRANSLATE_THERAPEUTICS_a pl.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\906\476\90647623\xml1\ APP0003.JPG |
SIGNATORY'S NAME | Sharon Walker |
SIGNATORY'S POSITION | Director, Legal |
SIGNATURE METHOD | Handwritten |
PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90647623 |
Filing Date: 04/15/2021 |
The applicant's current Correspondence Information: |
Christina M. Licursi |
PRIMARY EMAIL FOR CORRESPONDENCE: cxltrademarks@wolfgreenfield.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT
PROVIDED Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |